Plain-English translation of NCT07151339 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a long-term monitoring program for women who have experienced serious pregnancy-related blood pressure conditions, including preeclampsia, HELLP syndrome, or kidney disease during pregnancy. Researchers will track your health over time and collect blood and tissue samples to build a research database. The goal is to identify early warning signs and develop better ways to prevent heart and kidney problems in the years after pregnancy.
Women who have had these pregnancy complications face a higher risk of heart and kidney disease later in life, but there are currently limited programs to monitor and prevent these long-term problems. This study aims to fill that gap by providing specialized, ongoing care and research to keep you healthier.
You likely qualify if…
You likely don't qualify if…
You will be enrolled in a long-term monitoring program at the University Hospital. This observational study means the researchers will follow your regular medical care without changing your treatment plan. You will likely have periodic visits where your health is monitored, and you may be asked to donate blood or tissue samples for the research biobank. The study does not involve taking any new medications or undergoing experimental procedures.
AI-generated summary from trial data · Jul 19, 2026 · Not medical advice
Germany
Enrollment target
~100 participants
Started
November 2024
Primary completion
November 2029
Age range
18 Years and older
Sex
Female only
Last updated on clinicaltrials.gov in September 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Laura K Sievers, MD
University Hospital Schleswig-Holstein
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.